Natriuretic Peptide System Gene Variants Are Associated with Ventricular Dysfunction after Coronary Artery Bypass Grafting

Background:Ventricular dysfunction (VnD) after primary coronary artery bypass grafting is associated with increased hospital stay and mortality. Natriuretic peptides have compensatory vasodilatory, natriuretic, and paracrine influences on myocardial failure and ischemia. The authors hypothesized that natriuretic peptide system gene variants independently predict risk of VnD after primary coronary artery bypass grafting. Methods:A total of 1,164 patients undergoing primary coronary artery bypass grafting with cardiopulmonary bypass at two institutions were prospectively enrolled. After prospectively defined exclusions, 697 patients of European descent (76 with VnD) were analyzed. VnD was defined as need for at least 2 new inotropes and/or new mechanical ventricular support after coronary artery bypass grafting. A total of 139 haplotype-tagging single nucleotide polymorphisms (SNPs) within 7 genes (NPPA, NPPB, NPPC, NPR1, NPR2, NPR3, CORIN) were genotyped. SNPs univariately associated with VnD were entered into logistic regression models adjusting for clinical covariates predictive of VnD. To control for multiple comparisons, permutation analyses were conducted for all SNP associations. Results:After adjusting for clinical covariates and multiple comparisons within each gene, seven NPPA/NPPB SNPs (rs632793, rs6668352, rs549596, rs198388, rs198389, rs6676300, rs1009592) were associated with decreased risk of postoperative VnD (additive model; odds ratios 0.44–0.55; P = 0.010–0.036) and four NPR3 SNPs (rs700923, rs16890196, rs765199, rs700926) were associated with increased risk of postoperative VnD (recessive model; odds ratios 3.89–4.28; P = 0.007–0.034). Conclusions:Genetic variation within the NPPA/NPPB and NPR3 genes is associated with risk of VnD after primary coronary artery bypass grafting. Knowledge of such genotypic predictors may result in better understanding of the molecular mechanisms underlying postoperative VnD.

[1]  S. Aranki,et al.  Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting. , 2008, The Journal of thoracic and cardiovascular surgery.

[2]  Feng Gao,et al.  Alternative Splicing of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Is Associated With Plasma Low-Density Lipoprotein Cholesterol Response to Simvastatin , 2008, Circulation.

[3]  G. Figtree,et al.  Natriuretic peptides stimulate the cardiac sodium pump via NPR-C-coupled NOS activation. , 2008, American journal of physiology. Cell physiology.

[4]  J. Januzzi,et al.  Biology of the natriuretic peptides. , 2008, The American journal of cardiology.

[5]  Robert J Glynn,et al.  Natriuretic Peptide Precursor A Gene Polymorphisms and Risk of Blood Pressure Progression and Incident Hypertension , 2007, Hypertension.

[6]  M. Emdin,et al.  Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure. , 2007, Clinical chemistry.

[7]  H. Parving,et al.  Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  M. Emi,et al.  Linkage disequilibrium analyses of natriuretic peptide precursor B locus reveal risk haplotype conferring high plasma BNP levels. , 2007, Biochemical and biophysical research communications.

[9]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[10]  P. Rehak,et al.  N-Terminal Pro-brain Natriuretic Peptide Identifies Patients at High Risk for Adverse Cardiac Outcome after Vascular Surgery , 2007, Anesthesiology.

[11]  G. Baxter,et al.  Cardioprotective actions of peptide hormones in myocardial ischemia , 2007, Heart Failure Reviews.

[12]  D. Antoniucci,et al.  Relation between plasma brain natriuretic peptide, serum indexes of collagen type I turnover, and left ventricular remodeling after reperfused acute myocardial infarction. , 2007, The American journal of cardiology.

[13]  H. Jing,et al.  Brain natriuretic peptide limits myocardial infarct size dependent of nitric oxide synthase in rats. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[14]  Jeroen J. Bax,et al.  Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery , 2005, Heart.

[15]  L. Zagato,et al.  Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. , 2006, Journal of the American College of Cardiology.

[16]  G. Baron,et al.  Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: Association with postoperative cardiac dysfunction and 1-year mortality* , 2006, Critical care medicine.

[17]  G. Dedoussis,et al.  Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia , 2006, Journal of clinical laboratory analysis.

[18]  Luis Bolaños Cea.  Natriuretic peptide family: new aspects. , 2005, Current medicinal chemistry. Cardiovascular and hematological agents.

[19]  K. Mori,et al.  C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction. , 2005, Journal of the American College of Cardiology.

[20]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[21]  K. Nakao,et al.  Overexpression of Brain Natriuretic Peptide Facilitates Neutrophil Infiltration and Cardiac Matrix Metalloproteinase-9 Expression After Acute Myocardial Infarction , 2004, Circulation.

[22]  A. Ahluwalia,et al.  Natriuretic Peptide Receptor-C Regulates Coronary Blood Flow and Prevents Myocardial Ischemia/Reperfusion Injury: Novel Cardioprotective Role for Endothelium-Derived C-Type Natriuretic Peptide , 2004, Circulation.

[23]  Pardis C Sabeti,et al.  Genetic signatures of strong recent positive selection at the lactase gene. , 2004, American journal of human genetics.

[24]  R. Kazanegra,et al.  Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. , 2004, Journal of the American College of Cardiology.

[25]  Scott M. Williams,et al.  A high-density admixture map for disease gene discovery in african americans. , 2004, American journal of human genetics.

[26]  B. Gigante,et al.  Atrial Natriuretic Peptide Gene Polymorphisms and Risk of Ischemic Stroke in Humans , 2004, Stroke.

[27]  S. Gabriel,et al.  Assessing the impact of population stratification on genetic association studies , 2004, Nature Genetics.

[28]  G. Baxter,et al.  Autocrine and paracrine actions of natriuretic peptides in the heart. , 2004, Pharmacology & therapeutics.

[29]  P. Rizzon,et al.  Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype , 2003, Journal of hypertension.

[30]  P. Ferdinandy,et al.  B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. , 2003, American journal of physiology. Heart and circulatory physiology.

[31]  M. Sabatine,et al.  Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. , 2003, Journal of the American College of Cardiology.

[32]  A. Rynkiewicz,et al.  Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease. , 2003, American heart journal.

[33]  Alan S Maisel,et al.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.

[34]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[35]  Kenji Nakamura,et al.  Cardiac fibrosis in mice lacking brain natriuretic peptide. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Ridker,et al.  The gene encoding atrial natriuretic peptide and the risk of human stroke. , 1999, Circulation.

[37]  F. Salvi,et al.  A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives. , 1999, Journal of hypertension.

[38]  M. Yamauchi,et al.  The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[39]  N. Tamura,et al.  Significance of Vascular Natriuretic Peptide System in Vascular Remodeling in Humans and Its Application to Gene Therapy a , 1997, Annals of the New York Academy of Sciences.

[40]  J. D. Fisher,et al.  New York Heart Association Classification. , 1972, Archives of internal medicine.